Latest research news
08 January 2021
UCLH has begun recruiting participants to a trial looking at whether two antiviral drugs given to people who have tested positive for Covid-19 can stop the virus replicating.
Kết quả xổ số Quảng Nam30 December 2020
UCLH has welcomed the news that the Oxford-AstraZeneca coronavirus vaccine – which UCLH played a significant role in trialling – has today been approved for use in the UK.
Kết quả xổ số Quảng Nam25 December 2020
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
25 November 2020
A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.